To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
PHASE4CompletedINTERVENTIONAL
Enrollment
68
Participants
Timeline
Start Date
July 31, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
September 30, 2009
Conditions
Membranous Nephropathy
Interventions
DRUG
TW
TW,120mg/d
Trial Locations (1)
210002
Research Institute of Nephrology, Nanjing
All Listed Sponsors
lead
Nanjing University School of Medicine
OTHER
NCT00518219 - To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) | Biotech Hunter | Biotech Hunter